prednisolone has been researched along with Hypertriglyceridemia in 11 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
Hypertriglyceridemia: A condition of elevated levels of TRIGLYCERIDES in the blood.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Univariate and multivariate analysis showed that higher numbers of system or organ involvement in SLE, abdominal obesity, hypertriglyceridemia and daily prednisolone of ≥ 1 mg/kg/day were the important associated factors of SDM (P ≤ 0." | 3.81 | Steroid-induced diabetes mellitus in systemic lupus erythematosus patients: analysis from a Malaysian multi-ethnic lupus cohort. ( Gafor, AH; Kong, NC; Said, MS; Shaharir, SS, 2015) |
| "Hypercholesterolemia was observed in 46% to 80% and hypertriglyceridemia in 43% to 78% of sirolimus-treated patients during the first 6 posttransplantation months." | 3.72 | Dyslipidemia in renal transplant recipients treated with a sirolimus and cyclosporine-based immunosuppressive regimen: incidence, risk factors, progression, and prognosis. ( Chueh, SC; Kahan, BD, 2003) |
| " Dosing of these agents was concentration-controlled and open-labeled." | 2.71 | Bicêtre hospital experience with sirolimus-based therapy in human renal transplantation: the Sirolimus European Renal Transplant Study. ( Bäckman, L; Brattström, C; Calne, R; Campistol, JM; Charpentier, B; Claesson, K; Durand, D; Groth, CG; Kreis, H; Lang, P; Morales, JM; Touraine, JL; Wramner, L, 2003) |
| "Hypercholesterolemia was evident in 66." | 1.30 | Cardiovascular risk factors in long-term follow-up after orthotopic liver transplantation. ( Bechstein, WO; Guckelberger, O; Jonas, S; Kratschmer, B; Lemmens, HP; Luesebrink, R; Neuhaus, PL; Neuhaus, R, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (27.27) | 18.2507 |
| 2000's | 5 (45.45) | 29.6817 |
| 2010's | 2 (18.18) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Imai, M | 1 |
| Yamamoto, H | 1 |
| Hashimoto, T | 1 |
| Koyama, H | 1 |
| Kihara, S | 1 |
| Shaharir, SS | 1 |
| Gafor, AH | 1 |
| Said, MS | 1 |
| Kong, NC | 1 |
| Kuroda, T | 1 |
| Tanabe, N | 1 |
| Wakamatsu, A | 1 |
| Takai, C | 1 |
| Sato, H | 1 |
| Nakatsue, T | 1 |
| Wada, Y | 1 |
| Nakano, M | 1 |
| Narita, I | 1 |
| Huang, CS | 1 |
| Wu, WF | 1 |
| Nakajima, A | 1 |
| Doki, K | 1 |
| Homma, M | 1 |
| Sagae, T | 1 |
| Saito, R | 1 |
| Ito, S | 1 |
| Sumida, T | 1 |
| Kohda, Y | 1 |
| Charpentier, B | 1 |
| Groth, CG | 2 |
| Bäckman, L | 1 |
| Morales, JM | 1 |
| Calne, R | 1 |
| Kreis, H | 1 |
| Lang, P | 1 |
| Touraine, JL | 1 |
| Claesson, K | 1 |
| Campistol, JM | 1 |
| Durand, D | 1 |
| Wramner, L | 1 |
| Brattström, C | 2 |
| Pannu, HS | 1 |
| Singh, D | 1 |
| Sandhu, JS | 1 |
| Chueh, SC | 1 |
| Kahan, BD | 1 |
| Aakhus, S | 1 |
| Dahl, K | 1 |
| Widerøe, TE | 1 |
| Guckelberger, O | 1 |
| Bechstein, WO | 1 |
| Neuhaus, R | 1 |
| Luesebrink, R | 1 |
| Lemmens, HP | 1 |
| Kratschmer, B | 1 |
| Jonas, S | 1 |
| Neuhaus, PL | 1 |
| Wilczek, HE | 1 |
| Tydén, G | 1 |
| Böttiger, Y | 1 |
| Säwe, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Safety and Efficacy of Basiliximab, Delayed Dose Tacrolimus Plus ECMPA, Versus Standard Dose Tacrolimus, ECMPA Plus Corticosteroids in Patients Undergoing Liver Transplant[NCT02123108] | Phase 4 | 59 participants (Actual) | Interventional | 2011-01-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
(NCT02123108)
Timeframe: 12 months post liver transplant
| Intervention | Participants (Count of Participants) |
|---|---|
| Basiliximab | 3 |
| Tacrolimus Group | 4 |
(NCT02123108)
Timeframe: 12 months post liver transplantation
| Intervention | Participants (Count of Participants) |
|---|---|
| Basiliximab | 0 |
| Tacrolimus Group | 0 |
(NCT02123108)
Timeframe: 12 months post transplant
| Intervention | Participants (Count of Participants) |
|---|---|
| Basiliximab | 2 |
| Tacrolimus Group | 5 |
Number of participants who experienced dialysis independence or improvement based upon kidney function labs as a measure of renal recovery/ function following OLT in patients after undergoing orthotopic liver transplant (NCT02123108)
Timeframe: 12 months post-transplant
| Intervention | Participants (Count of Participants) |
|---|---|
| Basiliximab | 28 |
| Tacrolimus Group | 26 |
Participants at risk minus incidence of death within the first year post-transplant (NCT02123108)
Timeframe: 12 months post liver transplant
| Intervention | Participants (Count of Participants) |
|---|---|
| Basiliximab | 28 |
| Tacrolimus Group | 26 |
1 trial available for prednisolone and Hypertriglyceridemia
| Article | Year |
|---|---|
Bicêtre hospital experience with sirolimus-based therapy in human renal transplantation: the Sirolimus European Renal Transplant Study.
Topics: Adrenal Cortex Hormones; Azathioprine; Cyclosporine; Drug Therapy, Combination; France; Graft Reject | 2003 |
10 other studies available for prednisolone and Hypertriglyceridemia
| Article | Year |
|---|---|
Acquired marked hypertriglyceridemia with anti-GPIHBP1 antibodies.
Topics: Adolescent; Anti-Inflammatory Agents; Autoantibodies; Diet, Fat-Restricted; Female; Fenofibrate; Hum | 2020 |
Steroid-induced diabetes mellitus in systemic lupus erythematosus patients: analysis from a Malaysian multi-ethnic lupus cohort.
Topics: Adrenal Cortex Hormones; Adult; Antirheumatic Agents; China; Cohort Studies; Cross-Sectional Studies | 2015 |
High triglyceride is a risk factor for silent osteonecrosis of the femoral head in systemic lupus erythematosus.
Topics: Adolescent; Adult; Aged; Asymptomatic Diseases; Body Mass Index; Body Surface Area; Female; Femur He | 2015 |
Systemic lupus erythematosus associated with extreme hypertriglyceridemia.
Topics: Adolescent; Chylomicrons; Female; Humans; Hypertriglyceridemia; Lipoprotein Lipase; Lupus Erythemato | 2008 |
[Investigation of glucocorticoid-induced side effects in patients with autoimmune diseases].
Topics: Adult; Aged; Aged, 80 and over; Appetite; Autoimmune Diseases; Candidiasis, Oral; Dose-Response Rela | 2009 |
Lipid profile before and after renal transplantation--a longitudinal study.
Topics: Adult; Azathioprine; Biomarkers; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Cyclosporine | 2003 |
Dyslipidemia in renal transplant recipients treated with a sirolimus and cyclosporine-based immunosuppressive regimen: incidence, risk factors, progression, and prognosis.
Topics: Adult; Anti-Inflammatory Agents; Cardiovascular Diseases; Cohort Studies; Cyclosporine; Disease Prog | 2003 |
Hyperlipidaemia in renal transplant patients.
Topics: Adrenergic beta-Antagonists; Cardiovascular Agents; Cross-Sectional Studies; Cyclosporine; Diuretics | 1996 |
Cardiovascular risk factors in long-term follow-up after orthotopic liver transplantation.
Topics: Adolescent; Adult; Aged; Blood Glucose; Cardiovascular Diseases; Cyclosporine; Female; Follow-Up Stu | 1997 |
Hypertriglyceridemia in renal transplant recipients treated with sirolimus.
Topics: Adult; Aged; Azathioprine; Cholesterol; Drug Therapy, Combination; Humans; Hypertriglyceridemia; Imm | 1998 |